Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Biotech Turnaround Fund (BTF)

Investor type Venture Capital

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Looking for a perfect list of funds?

Get recommendations from our smart algorithm

Get the list
Total investments 7
Average round size
info
The average size of a deal this fund participated in
$19M
Portfolio companies 3
Rounds per year 0.33
Lead investments 0
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.57
Exits 1
Key employees Soon
Stages of investment
Late Stage Venture

Areas of investment

  • Biotechnology
  • Genetics
  • Medical Device
  • Life Science
  • Pharmaceutical
Summary

Biotech Turnaround Fund (BTF) appeared to be the VC, which was created in 2000. The leading representative office of defined VC is situated in the Bloemendaal. The company was established in Europe in The Netherlands.

Besides, a startup needs to be aged 6-10 years to get the investment from the fund. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular fund investment industries, there are Medical Device, Biopharma. Among the most popular portfolio startups of the fund, we may highlight Genizon BioSciences, CymaBay Therapeutics.

The typical case for the fund is to invest in rounds with 5-6 participants. Despite the Biotech Turnaround Fund (BTF), startups are often financed by MVI Finance, HBM Healthcare Investments AG, Carnegie Asset Management. The meaningful sponsors for the fund in investment in the same round are HBM Healthcare Investments AG, Investissement Desjardins, MVI Finance. In the next rounds fund is usually obtained by HBM Healthcare Investments AG, MVI Finance, BioFund Management.

Considering the real fund results, this VC is 6 percentage points less often commits exit comparing to other organizations. The fund is constantly included in less than 2 investment rounds annually. The top activity for fund was in 2003. The usual things for fund are deals in the range of 10 - 50 millions dollars. Opposing the other organizations, this Biotech Turnaround Fund (BTF) works on 15 percentage points less the average amount of lead investments. The top amount of exits for fund were in 2014.

Read more

Funds with similar focus

Funds from The Netherlands
Funds with similar focus located in The Netherlands:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Genizon BioSciences

Biotechnology
Genetics
Life Science
Medical Device
$30M01 Jan 2008 Montreal, Quebec, Canada

CymaBay Therapeutics

Biopharma
Biotechnology
Pharmaceutical
$32M19 Apr 2007 Hayward, California, United States

Genizon BioSciences

Biotechnology
Genetics
Life Science
Medical Device
$7M05 Feb 2007 Quebec

CymaBay Therapeutics

Biopharma
Biotechnology
Pharmaceutical
$27M29 Aug 2003 Hayward, California, United States

Genizon BioSciences

Biotechnology
Genetics
Life Science
Medical Device
$7M25 Feb 2003 Montreal, Quebec, Canada

Genizon BioSciences

Biotechnology
Genetics
Life Science
Medical Device
$16M12 Oct 2001 Montreal, Quebec, Canada

Genetics
Medical
Pharmaceutical
Therapeutics
$16M10 Oct 2001 Montreal, Quebec

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Biotech Turnaround Fund (BTF)?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: